BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett's Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia
Makaleler > Derleme · 2015
Yazarlar: Serhat BOR, Cathy Bennett, Paul Moayyedi, Douglas A. Corley, John DeCaestecker, Yngve Falck-Ytter, Gary Falk, Nimish Vakil, Scott Sanders, Michael Vieth, John Inadomi, David Aldulaimi, Khek-Yu Ho, Robert Odze, Stephen J. Meltzer, Eamonn Quigley, Stuart Gittens, Peter Watson, Giovanni Zaninotto, Prasad G. Iyer, Leo Alexandre, Yeng Ang, James Callaghan, Rebecca Harrison, Rajvinder Singh, Pradeep Bhandari, Raf Bisschops, Bita Geramizadeh, Philip Kaye, Sheila Krishnadath, M. Brian Fennerty, Hendrik Manner, Katie S. Nason, Oliver Pech, Vani Konda, Krish Ragunath, Imdadur Rahman, Yvonne Romero, Richard Sampliner, Peter D. Siersema, Jan Tack, Tony C. K. Tham, Nigel Trudgill, David S. Weinberg, Jean Wang, Kenneth Wang, Jennie Y. Y. Wong, Stephen Attwood, Peter Malfertheiner, David MacDonald, Hugh Barr, Mark K. Ferguson, Janusz Jankowski
AMERICAN JOURNAL OF GASTROENTEROLOGY, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2015, cilt 110, ss 662-682
DOI: 10.1038/ajg.2015.55
Özet
OBJECTIVES: Barrett's esophagus (BE) is a common premalignant lesion for which surveillance is recommended. This strategy is limited by considerable variations in clinical practice. We conducted an international, multidisciplinary, systematic search and evidence-based review of BE and provided consensus recommendations for clinical use in patients with nondysplastic, indefinite, and low-grade dysplasia (LGD).